drugset

drugset / Trial / NCT06752603

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

NCT06752603 ↗

Phase 2 Completed 57 enrolled Ono Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Timeline

Start: 2025-04-02
Primary completion: 2026-06-12
Completion: 2026-06-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ONO-1110	Unknown	—	—

Indications